{
  "topicName": "Diabetes - type 2",
  "topicId": "dba8b2b1-8488-45e6-9329-463370bd9023",
  "exportId": "ec3c9ebb-9004-4129-8cbd-aa8e00b792d1",
  "dataId": "ab36a795-9444-466a-ab73-aa9500ec926f",
  "number": 6,
  "dateOfExport": "2019-07-25T14:21:18.9241885+00:00",
  "nextPlannedReviewBy": "2021-12-31T23:59:59+00:00",
  "topicSummary": "Diabetes mellitus is a group of metabolic disorders characterized by persistent hyperglycaemia (HbA1c more than 48 mmol/mol [6.5%]",
  "lastRevised": "Last revised in July 2019",
  "terms": [
    {
      "code": "D003924",
      "term": "Diabetes Mellitus, Type 2"
    }
  ],
  "clinicalSpecialties": [
    "Cardiovascular",
    "Endocrine and metabolic",
    "Eyes",
    "Kidney disease and urology",
    "Preventative medicine"
  ],
  "aliases": ["Type 2 diabetes"],
  "topicHtmlObjects": [
    {
      "itemId": "3f1ed932-3379-45d7-b1b6-8d7064c09d89",
      "parentId": null,
      "rootId": "3f1ed932-3379-45d7-b1b6-8d7064c09d89",
      "fullItemName": "Summary",
      "htmlHeader": "<!-- begin field e0a1254e-c647-4bb8-b659-1978af02f1c9 --><h1>Summary: Diabetes - type 2</h1><!-- end field e0a1254e-c647-4bb8-b659-1978af02f1c9 -->",
      "htmlStringContent": "REPLACE_ON_SERVE",
      "containerElement": "topicSummary",
      "children": [],
      "depth": 1,
      "pos": 0
    }
  ],
  "latestChanges": [
    {
      "dateFrom": "2019-07-01T00:00:00+01:00",
      "dateTo": "2019-07-31T23:59:59+01:00",
      "title": "Minor update",
      "body": "Angioedema has been recognised as a very rare skin and subcutaneous tissue disorder in people taking dapagliflozin for type 2 diabetes."
    },
    {
      "dateFrom": "2019-05-01T00:00:00+01:00",
      "dateTo": "2019-05-31T23:59:59+01:00",
      "title": "Minor update",
      "body": "Prescribing information updated for liraglutide as the manufacturer advises that blood glucose self-monitoring is recommended to adjust dose of sulfonylurea and insulin, especially when liraglutide is started and insulin is reduced, using a stepwise approach. Diabetic ketoacidosis has been reported in insulin-dependent patients after rapid discontinuation or dose reduction of insulin ABPI, 2019."
    },
    {
      "dateFrom": "2017-08-01T00:00:00+01:00",
      "dateTo": "2017-08-31T23:59:59+01:00",
      "title": "Minor update",
      "body": "Bullous pemphigoid added as an adverse effect of gliptins as per updates to the manufacturer&#39;s summary of product characteristics."
    },
    {
      "dateFrom": "2017-05-01T00:00:00+01:00",
      "dateTo": "2017-05-31T23:59:59+01:00",
      "title": "Minor update",
      "body": "Information added on sodium&ndash;glucose cotransporter 2 (SGLT-2) inhibitors to reflect changes to NICE  guideline Type 2 diabetes in adults: management."
    },
    {
      "dateFrom": "2017-01-01T00:00:00+00:00",
      "dateTo": "2017-01-31T23:59:59+00:00",
      "title": "Minor update",
      "body": "Information added on organic cation transporters in the metformin prescribing section as per the manufacturer&#39;s Summary of Product Characteristics for glucophage. Information also added on drug interaction with St John&#39;s wort as per an update to the manufacturer&#39;s Summary of Product Characteristics for Diamicron."
    },
    {
      "dateFrom": "2016-12-01T00:00:00+00:00",
      "dateTo": "2016-12-31T23:59:59+00:00",
      "title": "Minor update",
      "body": ""
    },
    {
      "dateFrom": "2016-11-01T00:00:00+00:00",
      "dateTo": "2016-11-30T23:59:59+00:00",
      "title": "Minor update",
      "body": ""
    },
    {
      "dateFrom": "2016-10-01T00:00:00+01:00",
      "dateTo": "2016-10-31T23:59:59+00:00",
      "title": "Minor update",
      "body": "Increased lipase and increased amylase added as common adverse effects of liraglutide."
    },
    {
      "dateFrom": "2016-04-01T00:00:00+01:00",
      "dateTo": "2016-07-31T23:59:59+01:00",
      "title": "Reviewed",
      "body": "A literature search was conducted in April 2016 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of this topic. The recommendations have been updated in line with recommendations in the National Institute for Health and Care Excellence (NICE) guidelines Type 2 diabetes in adults: management (2015) and Diabetes (type 1 and type 2) in children and young people: diagnosis and management (2015)."
    }
  ]
}
